ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 107043 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 107043; 2) Community: the network communities that were significantly associated with the response to NSC 107043; 3) Molecule: the relationships between components within communities and NSC 107043; 4) MDR: the compounds that were significantly associated with the NSC 107043.

NSC Compound Enrichment Correlation
NSC 733504 Everolimus 0.0105972823829604 -0.15480686
NSC 736157 Null 0.0105972823829604 -0.24337374
NSC 740 Methotrexate 0.0105972823829604 0.35596379
NSC 759178 Pipamperone 0.0105972823829604 0.37929609
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0105972823829604 0.19535121
NSC 763703 (Z)-6-chloro-3-((2-(4-methoxyphenyl)-3H-benzo[d]imidazol-5-yl)methylene)indolin-2-one 0.0105972823829604 0.47163181
NSC 84074 Phosphonium, (3-bromopropyl)triphenyl- bromide 0.0105972823829604 0.30636062
NSC 10438 Azoresorcin 0.0119221520283057 0.42296924
NSC 109874 Benzimate, Carbendanim, Carbendazim 0.0119221520283057 0.39398698
NSC 136037 AT 116, benzylamine salt 0.0119221520283057 0.13361491
Total:113  Current:31    [First] [Prev] [Next] [Last]